4min chapter

Multiple Myeloma Hub cover image

Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learned from GRIFFIN and CASSIOPEIA trials?

Multiple Myeloma Hub

CHAPTER

The Impact of Daratumumab Maintenance Therapy on Progression-Free Survival in Multiple Myeloma Patients

This chapter delves into the role of daratumumab in enhancing progression-free survival for multiple myeloma patients after consolidation therapy. It explores key insights from trials like Griffin and Cassiopeia, emphasizing the advantages of ongoing daratumumab treatment and mentions current research efforts in this field.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode